Takeda's dengue vaccine meets goal in Phase 3 study - BioPharma Dive

Takeda's dengue vaccine meets goal in Phase 3 study  BioPharma Dive

Takeda's dengue vaccine met its primary goal in the first part of a Phase 3 study testing the treatment's ability to prevent the mosquito-borne tropical disease in ...